Myeloma cell-derived CXCL7 facilitates proliferation of tumor cells and occurrence of osteolytic lesions through JAK/STAT3 pathway
Abstract Osteolytic lesions and pathological fractures are hallmark manifestations of multiple myeloma (MM), profoundly influencing the quality of life and self-care ability of MM patients. By analyzing transcriptome data and single-cell RNA-seq data from our center and the GEO database, a subset of...
Saved in:
Main Authors: | Yue Wang, Tianwei Lan, Qiongyan Zhang, Chi Zhou, Peng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-025-07413-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
by: Wang Guanglian, et al.
Published: (2025-01-01) -
CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE
by: Zhanyun Da, et al.
Published: (2016-01-01) -
EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction
by: Rui Liu, et al.
Published: (2025-01-01) -
Arthralgia and Osteolytic Lesions Associated with Traumatic Pancreatitis in a 10-Year-Old Girl
by: Masayuki Obatake, et al.
Published: (2009-01-01) -
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma
by: Dirk Hose, et al.
Published: (2024-12-01)